Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,918.50
(
-0.14%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
90.95
(
0.30%
)
Bitcoin
75,956.00
(
0.08%
)
News Focus
News Focus
Post# of 257431
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: DewDiligence post# 224464

Thursday, 04/04/2019 7:09:35 PM

Thursday, April 04, 2019 7:09:35 PM

Post# of 257431
https://bioprocessintl.com/bioprocess-insider/facilities-capacity/with-sandoz-alder-confident-no-supply-headache-for-migraine-mab/

With Sandoz, Alder confident no supply headache for migraine MAb
by Dan Stanton
Wednesday, February 27, 2019 3:54 am
Alder BioPharmaceuticals has extended a supply agreement with Novartis subsidiary Sandoz to provide the drug substance for eptinezumab, its migraine candidate anticipated to launch next year.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today